Breaking News

You are here » Indian-Commodity  :  Top News  :  AstraZeneca Pharma India launches 'XIGDUO XR'

13-Feb2018

AstraZeneca Pharma India launches 'XIGDUO XR'

AstraZeneca Pharma India has initiated the commercial launch of XIGDUO XR, a product of AstraZeneca Group and has been approved in 61 countries to date including US, EU and Japan.

XIGDUO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.

Earlier, the company had announced that FDC of Dapagliflozin + Metformin Hydrochloride film coated tablets (XIGDUO XR) was expected to be launched in India in Q4 of FY 2017-18.

AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The company operates through two segments Healthcare and Clinical Trial.



Related News

View all news

Crude oil futures end lower on Tuesday

Crude oil futures ended lower on Tuesday with benchmark finishing at its lowest in over a year, as investor attention remained fixed on supply ahead of a key meeting of major oil producers early next month.......

Gold futures end tad lower on Tuesday

Gold futures ended marginally lower on Tuesday, retreating from four-day winning streak, owing to a firmer US currency amid better than expected US housing data. Meanwhile, investors were cautious as they......

Copper futures end lower as world stocks fall

Copper futures ended lower on Tuesday, as world stock markets fell in a tech-led sell-off, while the dollar index rallied from a two-week low, making commodities priced in the greenback more expensive......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......